BIO VIEW (Israel) Today

Equity ratings for BIO VIEW are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of August 2021 and ending today, the 11th of August 2022. Click here to learn more.
BIO VIEW cannot be verified against its exchange. It appears that BIO VIEW is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

BIO VIEW Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. BIO VIEW's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BIO VIEW or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
BIO VIEW is not yet fully synchronised with the market data
BIO VIEW has some characteristics of a very speculative penny stock
BIO VIEW has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 27.22 M. Net Loss for the year was (1.37 M) with profit before overhead, payroll, taxes, and interest of 14.76 M.
Co-CEO, DirectorYuval Harari
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BIO VIEW's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
BIO VIEW (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 12 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.73 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BIO VIEW's market, we take the total number of its shares issued and multiply it by BIO VIEW's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BIO VIEW operates under Healthcare sector and is part of Medical Devices industry. The entity has 14.2 M outstanding shares. BIO VIEW has accumulated about 17.67 M in cash with 755 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.
Check BIO VIEW Probability Of Bankruptcy

BIO VIEW Stock Against Markets

Picking the right benchmark for BIO VIEW stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BIO VIEW stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BIO VIEW is critical whether you are bullish or bearish towards BIO VIEW at a given time.
BIO VIEW cannot be verified against its exchange. It appears that BIO VIEW is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

BIO VIEW Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BIO VIEW stock to make a market-neutral strategy. Peer analysis of BIO VIEW could also be used in its relative valuation, which is a method of valuing BIO VIEW by comparing valuation metrics with similar companies.
MAGIC SOFTWARE ENTE SCHNAPP WORKSAmn Healthcare ServicesTwist Bioscience CorpFreedom Holding CorpKEURIG DR PEPPERGX Nasdaq-100 CoveredFranklin Mutual EuropeanGARDNER DENVER INCUSA Value FactorBetapro Canadian GoldAramark Holdings CorpLong-Term Govt BondLIFE STORAGE INCMaiden Holdings North
 Risk & Return  Correlation

BIO VIEW Corporate Directors

BIO VIEW corporate directors refer to members of a BIO VIEW board of directors. The board of directors generally takes responsibility for the BIO VIEW's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of BIO VIEW's board members must vote for the resolution. The BIO VIEW board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Eliane Markowitz - External DirectorProfile
Yacha Sutton - DirectorProfile
Jackie RosenblumGoren - External DirectorProfile
Lior Shav - DirectorProfile

Invested in BIO VIEW?

You need to understand the risk of investing before taking a position in BIO VIEW. The danger of trading BIO VIEW is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BIO VIEW is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BIO VIEW. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BIO VIEW is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities. Note that the BIO VIEW information on this page should be used as a complementary analysis to other BIO VIEW's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Tools for BIO VIEW Stock

When running BIO VIEW price analysis, check to measure BIO VIEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO VIEW is operating at the current time. Most of BIO VIEW's value examination focuses on studying past and present price action to predict the probability of BIO VIEW's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO VIEW's price. Additionally, you may evaluate how the addition of BIO VIEW to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go